Przejdź do treści

Filtry

Dane naukowe

Podręcznik/instrukcje

Aktualności

No evidence to support or refute the use of ischaemic preconditioning in liver transplantation

Także dostęne w

Ischaemic preconditioning is a mechanism for reducing organ ischaemia reperfusion injury by a brief period of organ ischaemia, ie, decrease the injury caused by return of blood supply to the organ after a period of decreased or absent blood supply by exposing the organ to shorter periods of decreased blood supply. There is considerable controversy regarding whether ischaemic preconditioning during donor liver retrieval has beneficial effect on the outcome of liver transplantation. This systematic review includes five randomised clinical trials assessing the advantages and disadvantages of ischaemic preconditioning during donor hepatectomy for liver transplant recipients. In four trials, 270 cadaveric liver donor retrievals were randomised; 131 to ischaemic preconditioning and 139 to no ischaemic preconditioning; and in one trial, 15 living donor liver retrievals were randomised; 10 to ischaemic preconditioning and 5 to no ischaemic preconditioning. All the trials were high bias-risk trials. There was no statistically significant difference in mortality, initial poor function, re-transplant, primary graft non-function, or in any other outcome other than enzyme markers of liver injury, which was in different directions in different trials. There is currently no evidence to support or refute the use of ischaemic preconditioning in donor liver retrievals. Further studies are necessary to identify the optimal ischaemic preconditioning stimulus.

Wprowadzenie

Ischaemic preconditioning is a mechanism for reducing organ ischaemia reperfusion injury by a brief period of organ ischaemia.

Cele

To assess the advantages and disadvantages of ischaemic preconditioning during donor hepatectomy for liver transplant recipients.

Metody wyszukiwania badań

We searched The Cochrane Hepato-Biliary Group Controlled Trials Register, the Cochrane Central Register of Controlled Trials (CENTRAL) in The Cochrane Library, MEDLINE, EMBASE, and Science Citation Index Expanded until June 2008.

Kryteria doboru badań

We included only randomised clinical trials comparing ischaemic preconditioning versus no ischaemic preconditioning during donor liver retrievals performed in humans in this review (irrespective of language or publication status).

Zbieranie i analiza danych

Two authors independently identified the trials for inclusion and independently collected the data on the characteristics of the trial, bias-risk of the trials, mortality, initial poor function, primary graft non-function, re-transplantation, intensive therapy unit stay, hospital stay, and liver function tests. We analysed the data with both the fixed-effect and the random-effects models. For each binary outcome we calculated the risk ratio (RR) with 95% confidence intervals (CI) based on available case analysis. For continuous outcomes, we calculated the mean difference (MD) with 95% CI.

Główne wyniki

In four trials, 270 cadaveric liver donor retrievals were randomised; 131 to ischaemic preconditioning and 139 to no ischaemic preconditioning. In one trial, 15 living donor liver retrievals were randomised; 10 to ischaemic preconditioning and 5 to no ischaemic preconditioning. All trials were high bias-risk trials. There was no statistically significant difference in mortality, initial poor function, primary graft non-function,re-transplant, intensive therapy unit stay, or hospital stay between the liver transplant recipients belonging to the two groups. There was no consistent pattern noted in the transaminase activity. There was no statistically significant difference in the bilirubin level or prothrombin activity.

Wnioski autorów

There is currently no evidence to support or refute the use of ischaemic preconditioning in donor liver retrievals. Further studies are necessary to identify the optimal ischaemic preconditioning stimulus.

Cytowanie
Gurusamy KS, Kumar Y, Sharma D, Davidson BR. Ischaemic preconditioning for liver transplantation. Cochrane Database of Systematic Reviews 2008, Issue 1. Art. No.: CD006315. DOI: 10.1002/14651858.CD006315.pub2.

Używamy plików cookie

Używamy niezbędnych plików cookie, aby nasza strona mogła działać. Chcielibyśmy również ustawić opcjonalne pliki cookie do analizy, aby pomóc nam udoskonalić tę stronę. Nie będziemy ustawiać opcjonalnych plików cookie, chyba że je włączysz. Użycie tego narzędzia spowoduje ustawienie pliku cookie na Twoim urządzeniu, aby zapamiętać Twoje preferencje. W każdej chwili możesz zmienić swoje preferencje dotyczące plików cookie, klikając na link "Ustawienia plików cookie" znajdujący się w stopce każdej strony.
Bardziej szczegółowe informacje na temat używanych przez nas plików cookie można znaleźć na naszej stronieStrona plików cookies

Zaakceptuj wszystkie
Skonfiguruj